CD5 and lung carcinoma: This is consistent with a report of increased anti-tumor cytolytic activity in T cells with low CD5 levels where TILs isolated from lung cancer patients exhibited differential anti-tumor activity where CD5 levels were negatively correlated with that anti-tumor activity (22).